As of Dec 02
| +0.08 / +4.40%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +163.16% increase from the last price of 1.90.
The current consensus among 3 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.